investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of Angiogenesis Inhibitors

William Figg

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Neil Vargesson

University of Aberdeen

Aberdeen, United Kingdom

Related projects

Hans-Martin Herz

Trithorax-related, MLL3 and MLL4 in enhancer-mediated cancer pathogenesis

All cancers but non-melanoma skin cancer

Mark Udey

EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology

All cancers but non-melanoma skin cancer

Christine Mayr

Dissecting the role of alternative 3UTRs in cancer with 3-seq

All cancers but non-melanoma skin cancer

Pathology

Sharon Y. R. Dent

Functions of Mammalian Histone Modifiers

All cancers but non-melanoma skin cancer

Jennifer Q Zhang

Tyrosine kinase inhibition and immunomodulation for cancer

All cancers but non-melanoma skin cancer

Joshi J Alumkal

The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer

Prostate

Pathology

Hans Schreiber

Immunology of Unique Tumor Specific Antigens

Prostate

Douglas R Green

RIPK-Dependent Necrosis in Development and Cancer

All cancers but non-melanoma skin cancer

Bjoern Markus Reinhard

Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor

All cancers but non-melanoma skin cancer